TYK2 Inhibitors: Transforming Autoimmune Disease Management

σε πρόσθεσε στο Health

2025-11-13 10:44:56

The TYK2 Inhibitors Market has emerged as a promising area in targeted therapy. Tyrosine kinase 2 (TYK2), a member of the Janus kinase (JAK) family, is essential in regulating cytokine signaling pathways that control immune responses and inflammation. Growing evidence of TYK2’s involvement in autoimmune and inflammatory conditions has driven the development of TYK2 Inhibitors drugs aimed...

0 Σχόλια 0 Μοιράστηκε 87 Views 0 Προεπισκόπηση